CYCLO THERAPEUTICS INC's ticker is CYTH and the CUSIP is 23254X201. A total of 14 filers reported holding CYCLO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $125 | -90.9% | 88 | -94.6% | 0.00% | – |
| Q1 2023 | $1,378 | -65.5% | 1,640 | -41.6% | 0.00% | – |
| Q4 2022 | $3,990 | +99.5% | 2,810 | +254.4% | 0.00% | – |
| Q2 2022 | $2,000 | -71.4% | 793 | -65.4% | 0.00% | – |
| Q1 2022 | $7,000 | -85.4% | 2,291 | -82.3% | 0.00% | – |
| Q4 2021 | $48,000 | -82.2% | 12,911 | -67.7% | 0.00% | – |
| Q3 2021 | $269,000 | +138.1% | 39,914 | +259.8% | 0.00% | – |
| Q2 2021 | $113,000 | +1783.3% | 11,094 | +1489.4% | 0.00% | – |
| Q1 2021 | $6,000 | – | 698 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| XTX Topco Ltd | 12,900 | $18,318 | 0.00% |
| Virtu Financial LLC | 10,732 | $15 | 0.00% |
| Tower Research Capital LLC (TRC) | 6,767 | $9,609 | 0.00% |
| JPMORGAN CHASE & CO | 240 | $341 | 0.00% |
| ROYAL BANK OF CANADA | 746 | $1,000 | 0.00% |
| VANGUARD GROUP INC | 282,027 | $400,478 | 0.00% |
| UBS Group AG | 88 | $125 | 0.00% |
| IFP Advisors, Inc | 13 | $18 | 0.00% |
| OSAIC HOLDINGS, INC. | 600 | $852 | 0.00% |
| WELLS FARGO & COMPANY/MN | 2,352 | $3,340 | 0.00% |